Literature DB >> 16274753

Regulatory studies of murine methylenetetrahydrofolate reductase reveal two major promoters and NF-kappaB sensitivity.

Laura Pickell1, Pamela Tran, Daniel Leclerc, John Hiscott, Rima Rozen.   

Abstract

Two promoters of the murine methylenetetrahydrofolate reductase gene (Mthfr), a key enzyme in folate metabolism, were characterized in Neuro-2a, NIH/3T3 and RAW 264.7 cells. Sequences of 189 bp and 273 bp were sufficient to achieve maximal activity of the upstream and downstream promoter, respectively. However, subtle differences in minimal promoter lengths and in promoter activities were observed between the cell lines. Both promoters demonstrated comparable activity in NIH/3T3 and RAW 264.7 cells, while in Neuro-2a cells, the upstream promoter was 15-fold more active than the downstream promoter. Alignment and data mining tools identified a candidate nuclear factor kappa B (NF-kappaB) binding site at the 3'end of the downstream promoter that is conserved throughout several species. NF-kappaB activation experiments in cultured cells were associated with increased Mthfr mRNA. Co-transfection of NF-kappaB and promoter constructs demonstrated Mthfr up-regulation by at least 2-fold through its downstream promoter in Neuro-2a cells; this increase was significantly reduced when the putative binding site was mutated. EMSA analysis demonstrated direct binding of NF-kappaB to this non-mutated site. This study, a first step into the elucidation of Mthfr regulation, demonstrates that two TATA-less, GC-rich promoters differentially drive transcription of Mthfr in a cell-specific manner, and provides a novel link of Mthfr to possible roles in the immune response and cell survival.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16274753     DOI: 10.1016/j.bbaexp.2005.09.002

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  5 in total

1.  Targeted insertion of two Mthfr promoters in mice reveals temporal- and tissue-specific regulation.

Authors:  Laura Pickell; Qing Wu; Xiao-Ling Wang; Daniel Leclerc; Hana Friedman; Alan C Peterson; Rima Rozen
Journal:  Mamm Genome       Date:  2011-07-19       Impact factor: 2.957

2.  Valproic acid increases expression of methylenetetrahydrofolate reductase (MTHFR) and induces lower teratogenicity in MTHFR deficiency.

Authors:  Marc Roy; Daniel Leclerc; Qing Wu; Sapna Gupta; Warren D Kruger; Rima Rozen
Journal:  J Cell Biochem       Date:  2008-10-01       Impact factor: 4.429

3.  Modeling gene-by-environment interaction in comorbid depression with alcohol use disorders via an integrated bioinformatics approach.

Authors:  Richard C McEachin; Benjamin J Keller; Erika F H Saunders; Melvin G McInnis
Journal:  BioData Min       Date:  2008-07-17       Impact factor: 2.522

4.  A plasma proteomics method reveals links between ischemic stroke and MTHFR C677T genotype.

Authors:  Zhenchang Zhang; Qi Yan; Jia Guo; Xueping Wang; Wei Yuan; Lei Wang; Lixia Chen; Gang Su; Manxia Wang
Journal:  Sci Rep       Date:  2017-10-17       Impact factor: 4.379

5.  The gene expression profile of a drug metabolism system and signal transduction pathways in the liver of mice treated with tert-butylhydroquinone or 3-(3'-tert-butyl-4'-hydroxyphenyl)propylthiosulfonate of sodium.

Authors:  Alexandra B Shintyapina; Valentin A Vavilin; Olga G Safronova; Vyacheslav V Lyakhovich
Journal:  PLoS One       Date:  2017-05-03       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.